Mason Street Advisors’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-7,882
| Closed | -$231K | – | 1526 |
|
|
2017
Q3 | $231K | Buy |
7,882
+214
| +3% | +$5.99K | 0.01% | 1285 |
|
|
2017
Q2 | $201K | Buy |
7,668
+468
| +7% | +$11.5K | 0.01% | 1292 |
|
|
2017
Q1 | $168K | Buy |
7,200
+474
| +7% | +$11.7K | ﹤0.01% | 1323 |
|
|
2016
Q4 | $169K | Buy |
6,726
+393
| +6% | +$9.92K | ﹤0.01% | 1309 |
|
|
2016
Q3 | $178K | Buy |
6,333
+325
| +5% | +$8.33K | 0.01% | 1247 |
|
|
2016
Q2 | $148K | Buy |
6,008
+583
| +11% | +$14.5K | ﹤0.01% | 1264 |
|
|
2016
Q1 | $120K | Buy |
5,425
+516
| +11% | +$13.7K | ﹤0.01% | 1291 |
|
|
2015
Q4 | $172K | Buy |
4,909
+426
| +10% | +$13.3K | 0.01% | 1150 |
|
|
2015
Q3 | $128K | Buy |
4,483
+285
| +7% | +$9.57K | ﹤0.01% | 1223 |
|
|
2015
Q2 | $140K | Buy |
4,198
+194
| +5% | +$5.96K | ﹤0.01% | 1221 |
|
|
2015
Q1 | $113K | Buy |
4,004
+130
| +3% | +$3.23K | ﹤0.01% | 1266 |
|
|
2014
Q4 | $80K | Buy |
3,874
+123
| +3% | +$2.92K | ﹤0.01% | 1753 |
|
|
2014
Q3 | $92K | Sell |
3,751
-19
| -0.5% | -$504 | ﹤0.01% | 1693 |
|
|
2014
Q2 | $108K | Buy |
3,770
+141
| +4% | +$3.92K | ﹤0.01% | 1653 |
|
|
2014
Q1 | $102K | Sell |
3,629
-1,052
| -22% | -$25.8K | ﹤0.01% | 1640 |
|
|
2013
Q4 | $101K | Buy |
4,681
+304
| +7% | +$5.53K | ﹤0.01% | 1698 |
|
|
2013
Q3 | $58K | Buy |
4,377
+262
| +6% | +$3.53K | ﹤0.01% | 1661 |
|
|
2013
Q2 | $57K | Buy |
+4,115
| New | +$58.3K | ﹤0.01% | 1589 |
|
Mason Street Advisors's PMC Position: Q4 2017 in Review
Mason Street Advisors sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 7,882 shares — an estimated $231K sold.
Mason Street Advisors first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $231K in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Mason Street Advisors reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Mason Street Advisors sold 7,882 PharMerica Corporation shares in Q4 2017, an estimated $231K.
- Mason Street Advisors first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Mason Street Advisors's PharMerica Corporation position peaked at $231K in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Mason Street Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.